Anti-Aging Treatments at Forefront of Astellas’ €80M UK Acquisition
Japanese pharma giant Astellas has acquired the UK biotech Nanna Therapeutics for up to €80M…
Japanese pharma giant Astellas has acquired the UK biotech Nanna Therapeutics for up to €80M…
The Swedish synthetic biology company EnginZyme has raised a Series A funding round to the…
The Swiss biotech FoRx Therapeutics has raised an impressive €10M in seed funding to develop…
The first European vaccine for coronavirus disease to enter clinical trials has been administered to…
The UK company MicrofluidX has closed a €1.6M (£1.4 M) seed funding round to develop…
The UK cell conversion startup Mogrify and the US genomic medicine company Sangamo have reached…
The French VC firm Sofinnova Partners has invested €20M in three Italian biotech companies via…
The French startup Phost’in Therapeutics has raised €10.3M to take its cancer immunotherapy drug against…
The Swiss pharmaceutical company Idorsia has announced that its drug candidate daridorexant significantly improved sleep…
The microbiome company LNC Therapeutics has entered into a licensing agreement to use a specific…
A new type of enzyme developed by the French company Carbios can break down more…
The Irish company Avectas has closed a Series C round to develop cell therapies that…